Fortrea Holdings COO Buys 11,006 Shares Amid Tax‑Driven RSU Sale—Signal of Confidence?Fortrea Holdings insider buys reveal executive confidence amid tax‑driven moves and high‑growth outlook—key signals for investors to watch.FORTREA HOLDINGS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 03/06/2026, 22:26 3 minutes to read
Fortrea Director’s Zero‑Cost RSU Settlement Signals Strong Insider Confidence Amid Volatile Stock PriceFortrea insiders settle RSUs, boosting confidence amid price swings – see how executive buys signal future growth and impact investors.FORTREA HOLDINGS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 18/05/2026, 22:59 3 minutes to read
Fortrea CFO’s “Tax‑Cover” Trades: Insider Keeps Stakes Steady Amid Stock SlumpFortrea Holdings insider trading: Chief Accounting Officer Robert Parks buys and sells RSUs to manage tax, signaling confidence or opportunism amid volatile stock price.FORTREA HOLDINGS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 11/03/2026, 22:39 4 minutes to read
Fortrea Executives Load Up on RSUs Amid Stock Dip, Betting on a Clinical‑Trial ComebackFortrea insider buys signal executive confidence in future growth: key leaders acquire RSUs as stock dips, hinting at long‑term upside for investors.FORTREA HOLDINGS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 10/03/2026, 22:00 3 minutes to read
Fortrea COO’s RSU Sell‑to‑Cover Trades Raise Questions About Cash Flow and Insider Confidence—Shares Slip 1.2% Ahead of Q4 Earnings ReleaseFortrea insider trading: COO Mark Morais’s RSU‑based sell‑to‑cover trades hint at cash‑flow strain and declining insider stake ahead of Q4 earnings.FORTREA HOLDINGS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 12/02/2026, 01:20 3 minutes to read